Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is more common in men, often linked to genetics and hormones.

Androgenetic alopecia is more common in men, linked to genetics and androgen levels, but routine pelvic ultrasound isn't recommended.

Hirsutism is relatively common among young Greek women.

Androgenetic alopecia negatively affects emotions and self-confidence, especially in younger people.

Family history affects hair loss severity and onset more in men than women.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.

Both hair transplantation and skin expansion are effective for treating cicatricial alopecia, with the best method depending on the patient's age, alopecia size, and other factors.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Baldness challenged men's self-image and masculinity in Britain from the late 19th to early 20th centuries, leading to a market for hair loss treatments.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Finasteride effectively treats male hair loss, increasing length and thickness.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Proper management of the dilation program is crucial after male-to-female reassignment surgery.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Testosterone therapy in transgender individuals can increase the risk of erythrocytosis.

Living with lupus as both a patient and doctor improved understanding and care for others.

Videodermoscopy better identifies female hair loss than clinical diagnosis.

Hormonal therapy in transgender patients can lead to skin changes like altered sebum production, hair growth, and acne, which may require dermatological care.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

Telogen effluvium is linked to deficiencies in iron, vitamin B12, and thyroid function.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Mint essential oils can kill parasites that cause cystic echinococcosis, with M. pulegium oil being more effective than M. piperita oil.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

Finasteride may help reduce prostate cancer risk.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.